USANA Q3 2025 Preview: Short-Term Challenges Amid Strategic Transition (NYSE:USNA)

Core Insights - USANA Health Sciences Inc. reported preliminary earnings for Q3 2025, leading to an initial share price decline of approximately 11% [1] Financial Performance - The company is currently undergoing a transitional period, which has affected investor sentiment [1] Company Background - USANA operates in the health sciences sector, focusing on nutritional products and dietary supplements [1]